{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:18:20Z","timestamp":1783397900303,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We report a rare case of cytomegalovirus (CMV) iridocyclitis and vitreoretinal lymphoma (VRL) that developed sequentially in the same eye during long-term infliximab (IFX) therapy for ulcerative colitis. This case highlights both the risk of opportunistic ocular infections and lymphoproliferative disorders coexisting in the same eye and the diagnostic challenges associated with prolonged immunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 65-year-old man presented to the ocular inflammatory service at Nippon Medical School Tama-Nagayama Hospital with deteriorating vision in the left eye. His medical history included IFX therapy for 11 years for ulcerative colitis, a 7-year history of bilateral primary open-angle glaucoma, and recurrent iridocyclitis in the left eye. Slit-lamp examination revealed mutton-fat keratic precipitates and dense vitreous opacities. Multiplex PCR of the aqueous humor detected CMV and Epstein-Barr virus (EBV). The cytological grading of the vitreous fluid was class IIIb. Cytokine analysis revealed an interleukin (IL)-10\/IL-6 ratio of &gt;\u20091.0, and immunoglobulin heavy chain gene rearrangement revealed monoclonality. Based on these findings, the patient was diagnosed with concurrent CMV iridocyclitis and VRL in the same eye. EBV positivity in the aqueous humor may have been associated with VRL development under prolonged immunosuppression. Topical ganciclovir was initiated for CMV iridocyclitis. The patient underwent bilateral ocular radiotherapy (40\u00a0Gy) and systemic chemotherapy with rituximab, methotrexate, procarbazine, and vincristine after IFX cessation. Although inflammatory and infiltrative lesions resolved, his final visual acuity was 20\/200 due to glaucomatous visual field loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present case highlights both the risk of opportunistic ocular infections and lymphoproliferative disorders associated with prolonged immunosuppression and the diagnostic challenge when both conditions coexist in the same eye. Careful monitoring and close collaboration between ophthalmologists and internists are essential for the early diagnosis and appropriate management of such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00594-x","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:55:03Z","timestamp":1778723703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concurrent cytomegalovirus iridocyclitis and vitreoretinal lymphoma in the same eye during long-term infliximab therapy: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Hitoshi","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Kunimatsu-Sanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4274\/tjo.59354","volume":"46","author":"S G\u00fcr G\u00fcng\u00f6r","year":"2016","unstructured":"G\u00fcr G\u00fcng\u00f6r S, Asena L, Akman A, G\u00f6kmen O (2016) Herpetic keratouveitis and trabeculectomy failure during infliximab therapy in a patient with Beh\u00e7et\u2019s disease. Turk J Ophthalmol 46:87\u201390","journal-title":"Turk J Ophthalmol"},{"key":"594_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10792-017-0532-4","volume":"38","author":"M Yoshida","year":"2018","unstructured":"Yoshida M, Yokokura S, Kunikata H, Takada N, Maruyama K, Toyokawa M, Kashio K, Kaku M, Nakazawa T (2018) Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy. Int Ophthalmol 38:841\u2013847","journal-title":"Int Ophthalmol"},{"key":"594_CR3","first-page":"440","volume":"118","author":"KH Sonoda","year":"2014","unstructured":"Sonoda KH, Fukuhara T, Yoshikawa H, Takeda A, Yoshimura T, Akahoshi M, Kusumoto H, Kohno K, Kato K, Akashi K, Kohashi K, Aijima S, Namba K, Ishibashi T (2014) A case report of malignant lymphoma receiving infliximab therapy with Beh\u00e7et\u2019s disease. Nippon Ganka Gakkai zasshi 118:440\u2013445","journal-title":"Nippon Ganka Gakkai zasshi"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2169\/internalmedicine.3274-23","volume":"64","author":"H Furusawa","year":"2025","unstructured":"Furusawa H, Shimada S, Sawada A, Tanaka K, Yamamoto K, Miyazaki Y (2025) Composite lymphoma after treatment with infliximab for sarcoidosis and ankylosing spondylitis. Intern Med 64:129\u2013132","journal-title":"Intern Med"},{"key":"594_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3960\/jslrt.19007","volume":"59","author":"M Tokuhira","year":"2019","unstructured":"Tokuhira M, Tamaru JI, Kizaki M (2019) Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop 59:72\u201392","journal-title":"J Clin Exp Hematop"},{"key":"594_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12348-020-00202-6","volume":"10","author":"FS Nicolela","year":"2020","unstructured":"Nicolela FS, Pavesio C (2020) A review of ocular adverse events of biological anti-TNF drugs. J Ophthal Inflam Infect 10:11","journal-title":"J Ophthal Inflam Infect"},{"key":"594_CR7","first-page":"251584142110708","volume":"14","author":"HV Neves da Silva","year":"2022","unstructured":"Neves da Silva HV, Placide J, Duong A, Ronquillo Y, McCabe S, Moshirfar M (2022) Ocular adverse effects of therapeutic biologics. Ther Adv Ophthalmol 14:25158414211070878","journal-title":"Ther Adv Ophthalmol"},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10384-018-0618-1","volume":"62","author":"D Shimizu","year":"2018","unstructured":"Shimizu D, Miyazaki D, Shimizu Y, Hosogai M, Kosugi I, Inoue Y (2018) Infection of endotheliotropic human cytomegalovirus of trabecular meshwork cells. Jpn J Ophthalmol 62:667\u2013676","journal-title":"Jpn J Ophthalmol"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/bjophthalmol-2014-306486","volume":"99","author":"M Hosogai","year":"2015","unstructured":"Hosogai M, Shima N, Nakatani Y, Inoue T, Iso T, Yokoo H, Yorifuji H, Akiyama H, Kishi S, Isomura H (2015) Analysis of human cytomegalovirus replication in primary cultured human corneal endothelial cells. Br J Ophthalmol 99:1583\u20131590","journal-title":"Br J Ophthalmol"},{"key":"594_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajo.2019.10.031","volume":"213","author":"S Nakano","year":"2020","unstructured":"Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimizu N, Sugita S, Strip PCR, Project Group (2020) Evaluation of a multiplex Strip PCR test for infectious uveitis: A prospective multicenter study. Am J Ophthalmol 213:252\u2013259","journal-title":"Am J Ophthalmol"},{"key":"594_CR11","doi-asserted-by":"publisher","first-page":"e1007040","DOI":"10.1371\/journal.ppat.1007040","volume":"14","author":"V Voigt","year":"2018","unstructured":"Voigt V, Andoniou CE, Schuster IS, Oszmiana A, Ong ML, Fleming P, Forrester JV, Degli-Esposti MA (2018) Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye. PLOS Pathog 14:e1007040","journal-title":"PLOS Pathog"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ceo.14328","volume":"52","author":"ML Lin","year":"2024","unstructured":"Lin ML, Hall AJ (2024) Uveitis masquerade syndromes: An approach to diagnosis. Clin Exp Ophthalmol 52:91\u2013105","journal-title":"Clin Exp Ophthalmol"},{"key":"594_CR13","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00417-018-4111-9","volume":"256","author":"D Miyazaki","year":"2018","unstructured":"Miyazaki D, Shimizu D, Shimizu Y et al (2018) Diagnostic efficacy of real-time PCR for ocular cytomegalovirus infections. Graefes Arch Clin Exp Ophthalmol 256:2413\u20132420","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2025.4358","volume":"334","author":"P Maghsoudlou","year":"2025","unstructured":"Maghsoudlou P, Epps SJ, Guly CM, Dick AD (2025) Uveitis in Adults: A Review. JAMA 334:419\u2013434","journal-title":"JAMA"},{"key":"594_CR15","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1136\/bjophthalmol-2020-317044","volume":"105","author":"MOM Wong","year":"2021","unstructured":"Wong MOM, Yu AHY, Chan CKM (2021) Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure. Br J Ophthalmol 105:1666\u20131671","journal-title":"Br J Ophthalmol"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaut.2017.02.001","volume":"80","author":"G Nocturne","year":"2017","unstructured":"Nocturne G, Boudaoud S, Ly B, Pascaud J, Paoletti A, Mariette X (2017) Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. J Autoimmun 80:56\u201364","journal-title":"J Autoimmun"},{"key":"594_CR17","doi-asserted-by":"publisher","first-page":"102453","DOI":"10.1016\/j.ajoc.2025.102453","volume":"40","author":"S Zafar","year":"2025","unstructured":"Zafar S, August AH, Milman T, Deaner JD (2025) Ebstein-Bar Virus (EBV)-Positive diffuse large B-cell vitreoretinal lymphoma: Two cases without overt immunocompromise and review of the literature. Am J Ophthalmol Case Rep 40:102453","journal-title":"Am J Ophthalmol Case Rep"},{"key":"594_CR18","doi-asserted-by":"publisher","first-page":"105079","DOI":"10.1016\/j.jcv.2022.105079","volume":"147","author":"S Silpa-Archa","year":"2022","unstructured":"Silpa-Archa S, Sriyuttagrai W, Foster CS (2022) Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review. J Clin Virol 147:105079","journal-title":"J Clin Virol"},{"key":"594_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","volume":"30","author":"R Tanaka","year":"2022","unstructured":"Tanaka R, Kaburaki T, Taoka K et al (2022) More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study. Ocul Immunol Inflamm 30:1354\u20131360","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"594_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2017.1352477","volume":"28","author":"M Harigai","year":"2018","unstructured":"Harigai M (2018) Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective. Mod Rheumatol 28(1):1\u20138","journal-title":"Mod Rheumatol"},{"key":"594_CR21","first-page":"431","volume":"128","author":"Y Hamano","year":"2024","unstructured":"Hamano Y, Io K, Yoshida Y, Iwahashi C, Miyake T, Umemura K, Haruta M, Minami T, Mashimo H, Ohguro N (2024) Development of intraocular lymphoma after treatment of cytomegalovirus retinitis: A case report. Nihon Ganka Gakkai Zasshi 128:431\u2013439","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"594_CR22","unstructured":"Japan Society for Neuro-Oncology. Clinical practice guidelines for primary central nervous system lymphoma (3rd edition). 2024. https:\/\/www.jsn-o.com\/guideline2024\/pcnsl2024.html. Accessed 7 Apr 2026"},{"key":"594_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.survophthal.2013.12.001","volume":"59","author":"MS Sagoo","year":"2014","unstructured":"Sagoo MS, Mehta H, Swampillai AJ et al (2014) Primary intraocular lymphoma. Surv Ophthalmol 59:503\u2013516","journal-title":"Surv Ophthalmol"},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bjh.14848","volume":"179","author":"T Kaburaki","year":"2017","unstructured":"Kaburaki T, Taoka K, Matsuda J et al (2017) Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma. Br J Haematol 179:246\u2013255","journal-title":"Br J Haematol"},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","volume":"25","author":"GD Shah","year":"2007","unstructured":"Shah GD, Yahalom J, Correa DD et al (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730\u20134735","journal-title":"J Clin Oncol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00594-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:01:44Z","timestamp":1783396904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00594-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors adhered to the code of ethics of the Department of Ophthalmology at Nippon Medical School Tama-Nagayama Hospital, Tokyo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of medical case details and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}